Phraxis Obtains $1,500,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2910 13th Terrace NW St. Paul, MN 55112
  • Company Description
    Phraxis, Inc. is an early stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first product for commercialization, the InterGraft, will be a percutaneously delivered arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy